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Abstract: High-resolution manometry (HRM) with closely spaced pressure sensors, enhances visualization 
and interpretation of esophageal pressures. HRM software displays two key physiological features of 
achalasia: inadequate swallow-induced lower esophageal sphincter (LES) relaxation, and the absence of 
normal esophageal primary peristalsis. HRM metrics quantify these features, by determining: (I) integrated 
relaxation pressure (IRP) of the esophagogastric junction (EGJ) during swallowing; and (II) esophageal body 
pressure patterns of absent or abnormal peristalsis, with high sensitivity for diagnosis of achalasia. These 
measures guide identification of three achalasia subtypes, through the Chicago classification of motility 
disorders. Achalasia subtypes stratify prevalent esophageal body pressure patterns with: subtype I, absent 
pressures (aperistalsis); subtype II, uniform pressures (esophageal pan pressurization); and subtype III, spasm 
pressures (spastic, premature or abnormal contractions). Whenever HRM reveals a non-relaxing EGJ, 
achalasia subtypes are front and center of the hierarchical classification process, with relevance to treatment 
outcomes. Exploration of pathophysiology suggests esophageal circular and longitudinal muscle function 
varies with achalasia subtype. Beyond the classification, an achalasia-like syndrome refers to a minority of 
patients where pressures do not meet criteria for achalasia subtypes, necessitating adjunct tests. Application of 
HRM in patients with achalasia can be challenging. Limitations during acquisition may occur with resistance 
at the EGJ or catheter curling, and esophageal pooling with successive water swallows. Interpretation 
requires care when EGJ relaxation pressure is within the normal range or affected by longitudinal muscle 
contraction. To overcome inconclusive HRM findings, strategies to clarify dysmotility include adjunct 
swallow challenge tests or additional investigations. Evolving manometric protocols, additional HRM 
metrics, and incorporation of intraluminal impedance will maximize HRM utility for achalasia. 
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Introduction
Esophageal high-resolution manometry (HRM) is the gold 
standard test for diagnosis of achalasia (1). The dominant 
symptom raising suspicion of achalasia is long standing 
dysphagia (2). Initial evaluation of dysphagia includes 
endoscopy and fluoroscopy (3), however many patients with 
achalasia, particularly in early stage of disease onset, are 
reported to have a normal endoscopy and barium swallow 
(4-6). Thus diagnosis of achalasia, a rare yet widely known 
motility disorder with no disease specific biomarker, is 
based on abnormal manometric pressures (7). 
The hallmark manometric features of achalasia, absence 
of normal peristalsis and incomplete esophagogastric 
junction (EGJ) relaxation on swallowing, are best recorded 
with HRM (8). Over the past decade, wide-spread uptake 
of HRM in clinical practice reflects the advantages of 
HRM technology over previous manometry systems 
(9,10). Accompanying the advancements in pressure sensor 
technology, computerization and analysis algorithms 
at the heart of HRM, is the development of a relevant 
classification system of esophageal motility disorders (11). 
Now in its third iteration, the Chicago classification guides 
interpretation of HRM findings (12,13). Front and center 
is recognition of manometric subtypes of achalasia that are 
clinically relevant for treatment outcomes. 
The utility of HRM and the Chicago classification v3.0, 
2015 (CCv3.0) (13) for the diagnosis of achalasia is ironically 
both simpler and more complex than ever before! HRM 
makes it easier to acquire good quality manometric studies 
(9,10). However, recent debate regarding training and 
competency in motility testing highlights the complexity 
of interpreting HRM findings (14,15). An additional layer 
is discovery and evolution. Five years have passed since the 
release of CCv3.0 and the International Working Group 
for Disorders of GI Motility & Function are in the process 
of formulating another update, with the release of Chicago 
classification v4.0 expected in 2020. 
For a review of the literature, electronic databases 
MEDLINE (PubMed), EMBASE (Ovid), and Cochrane 
Library (Cochrane Central Register of Controlled Trials) 
were searched from January 2008 to November 2019, 
subsequently updated in February 2020, to identify all 
relevant articles published. The search strategy was 
limited to (‘esophagus spasm/or esophagus achalasia’ OR 
achalasia’) AND (‘high resolution manometry’) AND/
OR (subtype I or subtype II or subtype III or classical or 
pressurization or spastic or type I or type II or type III or 
Chicago classification). Non relevant and duplicate papers 
were removed. Original full manuscripts of articles were 
reviewed. Bibliographies of relevant key-papers, review 
articles, meta-analyses and original articles were manually 
searched to identify additional publications.
This article reviews HRM and the current Chicago 
classification v3.0 for achalasia, with a focus on how the 
classification works, recent advances in HRM, and its 
limitations.
History
The recognition of disorder of motility related to 
dysphagia has a varied history. Achalasia was first described 
over 300 years ago, in 1674, by Sir Thomas Willis (16,17) 
and subsequently referred to as ‘cardiospasm’ until Dr. 
Arthur Hertz challenged this in 1915. Following post-
mortem examinations, Hertz proposed the problem 
was not cardiac sphincter spasm, but a lack of sphincter 
relaxation. As a direct consequence, the term ‘achalasia’ 
(fail to relax) was coined by Sir Cooper Perry (18). The 
recognition of achalasia long ago contrasts with more 
recent discovery of other motility disorders related to 
dysphagia. Epiphrenic diverticulum was recognised 
90 years ago by Mondiere in 1933 (19). While eosinophilic 
esophagitis noted by Landres et al. in 1978, appeared on 
endoscopy reports from 1990 (20).  
Intriguingly, descriptions of achalasia or ‘cardiospasm’ 
formed part of the medical literature long before acceptance 
of a lower esophageal sphincter (LES) (18,21). The first 
published manometry study recording LES pressure was 
in 1956 (22). Shortly thereafter the first guide to motility 
disorders, a book published in 1958, described just three 
disorders of esophageal motility: achalasia, diffuse spasm, 
and scleroderma esophagus (23). This pictorial atlas is a 
fascinating read of manometry from another era yet was 
published only 60 years ago!
The first motility classification system for water-
perfused manometry, using external pressure transducers, 
was proposed by Spechler & Castell in 2001, after review 
and analysis of the literature (24). Motility patterns 
were described by standardised criteria to distinguish six 
motility disorders, namely: achalasia; atypical disorders 
of LES relaxation; diffuse esophageal spasm; nutcracker 
esophagus; isolated hypertensive LES, and ineffective 
esophageal motility. Independently, a similar classification 
was devised and published a couple of months later by 
Richter (25).
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The advancement from low-resolution to HRM, 
with an increase in the number and proximity of closely 
spaced intraluminal pressure sensors, has revolutionised 
visualization and interpretation of luminal esophageal 
pressures (26). Visualization enhanced by the innovation of 
spatiotemporal contour plots, whereby pressure amplitudes 
are color  coded and interpolation of pressure values 
between recording sensors yields smooth topographic 
displays to create pressure maps (i.e., esophageal pressure 
topography or color contour plots) (27,28). Interpretation 
advanced in two-ways by (I) software development, with 
sophisticated algorithms for semi-automated data analysis 
plus new standardized topographic metrics for consistent 
analysis (26,29), and (II) classification of pressure analysis 
findings to aid diagnosis of major and minor motility 
disorders (11). Now called the ‘Chicago classification’ (9), 
this system was originally designed to categorize distal 
esophageal motor disorders focused on dysphagia (30), 
and continues to evolve with the intention for 3-yearly 
updates (13). The CCv3.0 uses a hierarchical approach to 
firstly categorize disorder of the EGJ and then disorder 
of esophageal peristalsis (13). Use of HRM is expanding, 
reflected by an increase in publications (of the top 10 
esophageal motility disorder papers, CCv3.0 has the highest 
citation rate) (31,32). Research and development, through 
a consensus process, will inform an update, Chicago 
classification 4.0.
Clinical presentation
Dysphagia, the perceived difficulty in swallowing with 
possible impaired bolus passage (33), is the main presenting 
symptom of several very different pathophysiological 
conditions. While the etiology of dysphagia cannot be 
diagnosed from symptoms, the circumstances of symptom 
onset can be informative. Sudden onset progressive 
dysphagia, particularly in middle-aged Caucasian men, is 
an alarm signal for carcinoma (34). Intermittent dysphagia 
to solids implies a benign structural disorder. Troublesome 
constant dysphagia to solids and liquids is more common 
with motility disorders (35). Motility disorders are more 
common in patients with dysphagia (53%) than patients 
with non-cardiac chest pain (28%) (36). Dysphagia is 
experienced by 90–100% patients with achalasia, less so 
regurgitation, chest pain and atypical symptoms: heartburn, 
cough and epigastric pain (2,37). 
A direct consequence of dysphagia in achalasia is altered 
bolus transport and food stasis (17,38). Some but not all 
patients report weight loss (4,6,39). Patients with heartburn 
are more likely to experience weight loss (39) and many are 
at risk of malnutrition (40). Other factors may be denial of 
weight loss associated with longer duration of symptoms, 
and achalasia subtype (see later) (41).
Questionnaires for patient self-reporting of symptoms 
bring to the fore dysphagia symptom severity and/or quality 
of life. The Eckardt score combines scores for dysphagia, 
regurgitation, chest pain and weight loss, all highly relevant 
in achalasia (42,43). In-depth dysphagia assessments include 
eating capacity assessment, such as: Dakkak and Bennett 
composite dysphagia score (44); the Mayo Dysphagia 
Questionnaire for scoring dysphagia in the preceding 
30-day (45); and a disease specific tool, the Achalasia 
Severity Questionnaire (46). These are all validated 
instruments for clinical use.
An appraisal of the aforementioned symptoms and 
signs, and noting any history of prior surgery around the 
hiatus is required, as primary idiopathic achalasia and 
secondary pseudoachalasia (of benign, malignant or surgical 
cause) (47,48) are conditions with similar symptoms and 
manometric findings (see article on pseudoachalasia in this 
issue).
Initial investigations
Endoscopy is a necessary first step for evaluation of 
dysphagia, to exclude obstruction associated with a stricture, 
tumour or inflammation (3,49). Features raising suspicion 
of achalasia such as a dilated esophagus, undigested food, 
or mild difficulty in passing the scope through the EGJ, 
are often but not consistently present (4). Studies reveal 
50–70% of patients with achalasia reportedly have a normal 
endoscopy (4,5). Knowledge of EGJ resistance or a dilated 
esophagus is helpful prior to manometry.
A radiographic barium swallow uti l iz ing video 
fluoroscopy may reveal typical findings of achalasia, namely: 
aperistalsis, a dilated esophagus (varying from mild to 
sigmoid shape), distal esophageal tapering with a ‘bird-beak’ 
shaped EGJ, and retention of contrast with poor esophageal 
emptying (5,50). These features may not be present in early 
stages of achalasia (4,51,52).
Endoscopy and fluoroscopy ideally precede manometry 
(to exclude other causes of dysphagia) and they may 
provide insight into anatomical anomalies for caution 
and care during manometry catheter insertion, as well as 
complementary information aiding interpretation of HRM 
findings (Figure 1).
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Figure 1 Video fluoroscopic swallow study (left, middle), showing dilated esophagus, distal esophageal tapering, ‘bird-beak’ shaped EGJ 
and marked distal esophageal angulation (necessitating a careful approach to pass the motility catheter across the EGJ during nasogastric 
intubation). Note however the manometry catheter did not traverse the EGJ (right). EGJ, esophagogastric junction.
High resolution manometry
Acquisition of esophageal HRM
In brief, esophageal HRM incorporates closely spaced (at 
1–2 cm) pressure sensors for measuring luminal pressures 
from the throat to the stomach. 
Preparation 
Preparation includes a 6-hr fast  and cessation of 
medications that alter upper gastro-intestinal motility 
for at least 48 hours (53). For patients with suspected 
achalasia, consumption of a liquid diet 48-hr prior is 
advised, to lower the risk of aspiration or vomiting during 
catheter intubation (54) and to provide a cleaner motility 
recording by reducing pressure artifact related to the 
presence of food in the esophagus.
Prior to HRM, an esophageal HRM catheter is connected 
to a biomedical pressure recording system, requiring sensor 
function check and two-point calibration (54). Current multi-
sensor solid-state HRM catheters consist of 32–36 pressures 
sensors, either unidirectional or averaged circumferential 
sensors, positioned at 1-cm spacing along the catheter length 
(53,55). The pressure sensors yield low voltage electrical 
signals, which are amplified, filtered and digitized for display 
in real-time with proprietary computer software (54).
Introducing the manometry catheter 
The prospect of a nasogastric intubation while awake is a 
daunting thought for most people (54) and may cause some 
anxiety related to ‘fear of the unknown’. A high-quality 
motility recording is dependent on both a well-trained 
operator and a co-operative patient (54,56). Thus, education 
on the purpose and nature of the test; assurance of brief 
instruction prior to each step; followed by verbal or written 
consent prior to intubation is important (54). Topical 
anaesthetic nasal spray (5% lignocaine) is applied to the 
most patent nostril 5-min prior to intubation, performed 
sitting or semi-upright while lying on a barouche, aided by 
water swallows.
Specific to patients with suspected achalasia, great care 
and attention is required when attempting to pass the 
manometry catheter across the EGJ. The risk of a motility 
catheter curling in the distal esophagus or not traversing the 
EGJ is greater in achalasia and/or dilated esophagus (57,58) 
with a failure rate of 7–12% (57-59). Further, during blind 
nasogastric intubation, subtle tactile feedback of resistance 
to passage across the EGJ will be missed if the catheter is 
not held lightly and passed gently. Successful intubations 
61F
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may require modified posture (left or right lateral) 
(54,60), or sometimes a deep breath or a gentle cough, 
for momentary axial separation of the lower sphincter and 
crural diaphragm, to allow passage of the catheter tip into 
the abdominal stomach. Once the catheter traverses the 
EGJ, the level of the crural diaphragm is identified with a 
deep breath or sniff to reveal the pressure inversion point. 
Above the inversion point, inspiration shows as negative 
intra-thoracic pressure; and below the inversion point, as 
positive intra-abdominal pressure (61).
HRM acquisition protocol
There are 3 essential elements: (I) correct positioning of 
the catheter for recording motility inclusive of two sensors 
above the upper sphincter (to observe swallow initiation) 
and at least three sensors beyond the EGJ on the gastric 
side; recording in the supine or semi-supine position (head 
of bed elevated by 10–15o); (II) after taping in position, a 
minimum 2-minute (up to 5-minute) acclimatization period 
with minimal swallowing is followed by a series of ten, 
5 mL water swallows at 30 s intervals i.e., spaced to ensure 
no interference from the previous wet or spontaneous 
swallow (25–30 s refractory period) (62,63); (III) the 
operator (scientist, technician, nurse or medical officer) 
requires specialist training and experience to recognise 
during acquisition: correct position, common artifacts, 
equipment failure and make ‘within study’ adjustments for 
technical adequacy or apply protocol variations to improve 
diagnostic yield (54,56).
Adjunct testing 
Although not part of the HRM protocol required for 
CCv3.0, additional swallow challenge tests and position 
change can prove helpful when findings are equivocal for 
achalasia (64,65). These adjunctive tests are designed to 
increase the workload for the esophagus and create a more 
realistic record of swallowing function or dysfunction 
(58,66). Multiple rapid swallows (MRS) involve five rapid 
sequence swallows, each of 2 mL water bolus at <3 s 
intervals during supine posture (67,68), optimally performed 
in triplicate (69). While a normal MRS response leads 
to inhibition of esophageal smooth muscle contractions; 
stimulates long and more complete EGJ relaxation; and 
gives rise to a vigorous peristaltic after contraction (67,70), 
these are abnormal/absent in patients with achalasia (71-73). 
Rapid drink challenge (RDC) involves free drinking of 
200 mL water to enhance detection of EGJ dysfunction and 
the physiological response of an obstructive EGJ pattern 
(74-76). Of relevance, the degree of incomplete EGJ 
relaxation during RDC correlates with dysphagia 
severity (74). Another option is the incorporation of five, 
5 mL water swallows during upright posture. EGJ pressures 
are lower during upright posture, however sustained 
abnormal EGJ relaxation with upright swallows better 
correlate with radiological EGJ obstruction, thus useful to 
assess EGJ dysfunction, including achalasia (77). 
Analysis of HRM pressure data
The bridge between the pressure data of manometry 
acquisition and a motility diagnosis using CCv3.0, is analysis 
of HRM data (78). Visualization of pressure data as color 
contour plots aids correct placement of markers for analysis 
algorithms (79). In brief, HRM metrics are determined for 
each standard wet swallow, including these key variables: (I) 
integrated relaxation pressure (IRP), an indication of residual 
EGJ pressure during swallow induced relaxation; (II) distal 
contractile integral (DCI), recording the contractile vigour 
for the distal esophagus of peristaltic or non-peristaltic 
contractions—an integral, a unit of measure for pressure 
magnitude for the period of a swallow over an axial length 
of contractile segment i.e., amplitude (mmHg) × duration 
time (s) × length (cm); (III) distal latency (DL), the time 
elapsed between swallow onset and arrival of the contraction 
in the distal esophagus. In addition to contractile vigour, 
the pattern of esophageal contractions is assessed for each 
wet swallow, for example: failed, intact, premature (rapid) 
or fragmented contractions. These metrics and patterns are 
utilised in the CCv3.0 to categorize motility disorders (13). 
The classification is intended to evaluate motility in patients 
with dysphagia without prior upper gastrointestinal surgery. 
The CCv3.0 includes guidelines to classify EGJ morphology, 
but hiatus hernia is uncommon in achalasia (4–5%) (80-82) 
and most patients with achalasia show complete overlap of 
LES and crural diaphragm pressures (EGJ type I), with or 
without transient separation during swallowing as a result of 
LES elevation (56,58).
The CCv3.0 follows a hierarchical approach, beginning 
with evaluation of EGJ relaxation, after which an evaluation 
of esophageal body function follows (13). 
Evaluation of EGJ relaxation
Esophageal emptying is dependent on flow through the 
EGJ, without which bolus transport is not achieved. 
Detection of an abnormally relaxing EGJ is required for an 
achalasia diagnosis (60). EGJ IRP or IRP-4s is a pressure 
Annals of Esophagus, 2020Page 6 of 21
© Annals of Esophagus. All rights reserved. Ann Esophagus 2020;3:24 | http://dx.doi.org/10.21037/aoe-2019-ach-10
topography metric, defined as the mean of 4s of maximum 
EGJ deglutitive relaxation occurring within a 10s timeframe 
from swallow onset. The 4s of EGJ relaxation may be 
contiguous or non-contiguous, to allow for interruptions by 
diaphragmatic contractions of respiration. IRP-4s (mmHg) 
referenced to gastric pressure, is recorded for 10 wet 
swallows, with initially mean and now median IRP-4s for 
classification (11,13,83,84).
In a landmark publication of 2007, Ghosh et al. explored 
a range of measures and criteria for EGJ relaxation and 
found the IRP-4s with a cut-off value of 15 mmHg* 
was optimal for separation of patients with and without 
achalasia (98% sensitivity; 96% specificity) (83,85). If the 
IRP-4s value is less than 15 mmHg, then EGJ relaxation is 
considered normal.
IRP-4s is however a complex metric measured across 
time (described above) and across axial EGJ length, between 
the proximal and distal axial margins i.e., several 1 cm-
spaced pressure sensors (84). This means IRP quantifies 
deglutitive EGJ relaxation for 4 s across a 3–5 cm axial 
length and is unlikely to capture LES relaxation alone. 
The dynamic EGJ environment is influenced by LES 
function, crural diaphragm function, distal esophageal 
luminal pressure during swallowing, as well as pressure 
associated with bolus presence. A rigorous study of IRP 
values by regression tree analysis and algorithm approach 
found EGJ relaxation by IRP is best assessed in context of 
esophageal pressure patterns (86). Thus in CCv3.0, the cut-
off IRP value of 15 mmHg is the upper limit of normal, 
with flexibility for borderline IRP when there is absence of 
peristalsis (i.e., for aperistalsis with borderline IRP, range, 
10–15 mmHg, consider achalasia) (13). This aspect is made 
further complex by different (higher) cut-off levels for 
alternative manometry systems (85) and decreased EGJ 
relaxation (higher IRP) in the elderly (87-89).
Evaluation of esophageal body function
During formulation of the first version of the Chicago 
classification (11) an in-depth analysis of HRM data in 
persons with impaired EGJ relaxation (90) identified three 
distinct subtypes of achalasia, namely subtype I, II, III, for 
esophagus showing absent pressures; uniform pressures; 
and spastic pressures respectively (Table 1; Figure 2). 
All achalasia subtypes are characterized by incomplete 
EGJ relaxation, so the subtype reflects the different but 
prevalent esophageal body pressure patterns of abnormal 
or absent peristalsis (12,90) (Figure 3). Subtype I and II 
are distinguished by esophageal pressurization of <30 or 
>30 mmHg, respectively. Upon swallowing, esophageal 
body pressure pattern shows absent pressures (subtype I) 
or pan esophageal pressurization with uniform pressure 
across the entire esophagus (subtype II). Subtype III is 
characterized by at least 20% of wet swallows with rapid 
i.e., premature contractions (defined as DL <4.5 s). Most 
importantly, treatment outcomes were different for the 
different subtypes, whether treating the poorly relaxing 
LES by paralysing it with Botulinum toxin; or disrupting 
the muscle fibres by pneumatic dilatation, or laparoscopic 
Heller myotomy. Notably 47/49 patients with subtype II 
had successful treatment, with just 4% treatment failure (cf. 
44%, 71% for subtype I & III respectively) (90). 
Inspired, Salvador et al. undertook retrospective 
subtyping of predominantly conventional manometry 
tracings for 246 patients, finding more treatment failures 
with subtype III (30%), cf. subtype II (5%) and I (14%) (91). 
A pivotal study followed, where Rohof et al. applied 
achalasia subtypes to manometric data for 176 patients 
already enrolled in the European achalasia trial (randomized: 
pneumatic dilatation, PD, or laparoscopic Heller myotomy, 
LHM). By subtypes, achalasia treatment success rates at 
2 years post treatment were best in subtype II (100% PD vs. 
95% LHM), less in subtype I (86% PD vs. 81% LHM), and 
worst in subtype III (40% PD vs. 86% LHM) (92). 
Several subsequent studies report various treatment 
modality outcomes by achalasia subtype (93), most 
confirming these findings (94-96), while others found 
similar treatment outcomes for subtypes (97-99). Long-
term outcome for the aforementioned European achalasia 
trial reveals that success at 5 years post treatment was best 
in subtype II (96% PD vs. 88% LHM), however success rate 
declined between years 2 and 5 for subtype I and II, while 
subtype III remained stable (48% PD vs. 86% LHM) (100). 
Two recent meta-analyses show older patients and 
achalasia subtype III were strongest predictors of clinical 
outcome (101); with recommendations for when to offer 
pneumatic dilatation, POEM and LHM (with a caveat that 
post treatment reflux data was not consistently available for 
analysis) (102). The concluding statement that personalized 
treatment for achalasia subtype could help achieve the 
best outcome (102) highlights the clinical importance of 
* Consult normative values for device in use (Herregods et al., Neurogastroenterol Motil 2015).
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Table 1 Achalasia subtypes, based on IRP-4s and esophageal pressure topography
Achalasia subtypes Criteria
Subtype I: Classic achalasia • Elevated median IRP-4s (>15 mmHg*)†
• 100% failed peristalsis (DCI <100 mmHg.s.cm) 
Premature contractions with DCI values less than 450 mmHg.s.cm satisfy criteria for 
failed peristalsis 
Subtype II: Achalasia with pressurization • Elevated median IRP-4s (>15 mmHg*)
• 100% failed peristalsis
• pan esophageal pressurization with ≥20% of swallows 
Contractions may be masked by esophageal pressurization and DCI should not be 
calculated
Subtype III: Spastic achalasia • Elevated median IRP-4s (>15 mmHg*)
• No normal peristalsis
• Premature (spastic DL <4.5 s) contractions with DCI >450 mmHg.s.cm with ≥20% of 
swallows 
May be mixed with pan esophageal pressurization
IRP-4s, integrated relaxation pressure (4 sec); DCI, distal contractile integral; DL, distal latency; pan esophageal pressurization refers to 
uniform pressure, which spans from EGJ to UES (gastroesophageal junction to upper sphincter). *, cut-off value is dependent on device; 
CCv3.0 based on Sierra (Medtronic) [consult normative values for device in use (85)]; †, borderline IRP (range, 10–15 mmHg) can consider 
achalasia subtype I. From: The Chicago Classification of esophageal motility v3.0: Kahrilas et al., 2015 (13). Reproduced with permission 
from John Wiley & Sons Ltd.
subtyping.
A major shift is underway. First, application of HRM and 
CCv3.0 is enabling improved classification of patients with 
achalasia into three achalasia subtypes, which can be applied 
consistently across all manometric acquisition and analysis 
systems (103). Second, single centre, multi-centre studies, 
and meta-analyses of treatment outcomes are an evidence 
base to assess treatment efficacy for an achalasia subtype. 
Third, individualized patient treatment is being realized, 
guided by therapeutic responses for specific achalasia 
subtypes. Different treatments for achalasia (pneumatic 
balloon dilatation, Botulinum toxin, laparoscopic Heller 
myotomy + Dor fundoplication, and per oral endoscopic 
myotomy) are reviewed separately (see subsequent articles 
in this issue). 
Subtype analysis in HRM
Achalasia subtype I
Evidence to date suggests that in achalasia subtype I, the 
Figure 2 Achalasia subtypes, based on IRP-4s and esophageal pressure topography. Adapted from The Chicago Classification of esophageal 
motility v3.0: Kahrilas et al., 2015 (13). Reproduced with permission from John Wiley & Sons Ltd.
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Figure 3 Pressure contour plots of achalasia subtypes, showing IRP-4s and esophageal pressure pattern: (A) Achalasia subtype I, (B) 
Achalasia subtype II, (C) Achalasia subtype III. Inset: EGJ eSleeve with [10 s timeframe] (black brackets) and [IRP-4s] (red shaded area) for 














absence of peristalsis and minimal esophageal pressurization 
in the distal smooth muscle of the esophagus relates to a 
large cross-sectional area; thin esophageal wall muscle; little 
or no longitudinal muscle contraction; and poor emptying. 
These features are compatible with a dilated esophagus that 
predominantly empties by gravity (104).
A dilated esophagus is most consistently observed 
in subtype I and also subtype II, although observations 
vary and do not discriminate subtypes (92,105,106). 
Regurgitation, a common symptom in achalasia, relates to 
greater lumen width rather than achalasia subtype (92,105).
IRP is more often within the normal range in achalasia 
subtype I than other achalasia subtypes (86,107), requiring 
careful attention during classification. It is important that 
low amplitude incomplete EGJ relaxation of achalasia 
subtype I, is not confused with an adynamic or scleroderma-
like esophagus, which features: absent or poor contractility, 
complete EGJ relaxation, and a high rate of reflux symptoms 
(38,108). If there is uncertainty of pressure characteristics 
with standard 5 mL wet swallows, several studies show 
adjunct swallow challenge tests may provide clarity (38,107) 
(Figure 4). However, swallow challenge tests may change 
the achalasia subtype (73,109). A MRS response may change 
a subtype I to subtype II, not unexpectedly as esophageal 
pooling may affect swallow pressurization from <30 to 
>30 mmHg, the distinguishing isocontour threshold. In 
such cases, the baseline 5 mL water swallow findings inform 
the diagnosis, with MRS providing supportive evidence. 
More studies are needed to build the evidence base for 
response characteristics of MRS in achalasia.
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Figure 4 Partial expression of achalasia 5 mL water swallow (integrated relaxation pressure IRP-4s =6.4 mmHg (A), prompting adjunct 
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Achalasia subtype II
Established early on and confirmed by a recent meta-
analysis, achalasia subtype II is the most common subtype 
(93,102). It features pan esophageal pressurization that 
spans the full length of the esophagus with at least 20% 
of wet swallows, followed often by EGJ contraction post 
swallow (110). Of the three subtypes, patients with achalasia 
subtype II show homogeneity of esophageal pressure 
pattern from swallow to swallow and elegant studies 
utilising HRM-impedance concurrently with intraluminal 
ultrasound images, suggest esophageal longitudinal muscles 
are responsible for esophageal emptying in subtype II 
(104,110). With each swallow, esophageal pressurization 
relates to a decrease in lumen size, increase in esophageal 
wall muscle thickness and an increase in luminal pressures. 
The observed pan esophageal pressurization most likely 
arises from longitudinal muscle elevating luminal cavity 
pressure, rather than non-lumen occlusive circular muscle 
contractions (111). 
Esophageal body pan-pressurization is a distinctive 
feature of achalasia subtype II. Regression tree analysis of 
HRM dataset reveals that the presence of esophageal body 
pan-pressurization in of itself is sufficient to establish the 
diagnosis of achalasia subtype II, without consideration of 
IRP. This statement seemingly contravenes the hierarchical 
analysis approach (Figure 2): first EGJ IRP, then esophageal 
body pressures, but it actually does not! The analysis simply 
establishes that esophageal pan-pressurization does not 
occur without EGJ outflow obstruction (86).
Achalasia subtype III
When classifying achalasia into different subtypes, 
inter- and intra-rater agreement is reported highest for 
classification of subtype III (103). In contrast, a study 
classifying a broader range of motility disorders, for 
36 participants registered with the international HRM 
Working Group, inter-rater agreement was substantial 
for aperistalsis, while moderate for achalasia subtype III 
(kappa 0.66; 0.56 respectively) (108). Similarly, in a multi-
center study of gastroenterology trainees undertaking 
HRM training and competency assessment for a range 
of motility disorders, diagnostic accuracy for achalasia 
subtype III was lower (58%) than for subtype I (87%) or 
subtype II (77%) (14). The co-presentation of incomplete 
EGJ relaxation (abnormal IRP) with spastic, premature or 
abnormal esophageal contractions of subtype III is very 
different from the other achalasia subtypes. However, there 
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is heterogeneity of this pressure pattern in subtype III (111), 
requiring careful attention to the HRM metrics and CCv3.0 
hierarchy for diagnostic interpretation. For the untrained, 
the presence of spastic esophageal contractions may lead to 
a presumptive diagnosis of distal esophageal spasm, when in 
fact CCv3.0 provides guidance: if simultaneous contractions 
occur together with incomplete EGJ relaxation, then 
the diagnosis is not distal esophageal spasm but achalasia 
subtype III (13,108). 
Two seminal papers expand our understanding of 
achalasia subtype III pathophysiology (111,112). A focus 
on esophageal contraction pattern and bolus clearance 
(combining HRM, impedance, and ultrasound), revealed 
that in subtype III esophageal contraction onset appears 
simultaneous, while the contraction peak and termination 
appear sequential. An observation compatible with 
esophageal contractions of short DL. The baseline 
esophageal wall muscle thickness (circular & longitudinal) 
are reported larger in subtype III compared with normal 
subjects, while axial shortening is similar. The authors 
speculate that muscle hypertrophy results in poor 
distensibility of the esophagus (112). Further, due to the 
short DL, a bolus travels much closer to the contraction 
wave, with elevated common cavity pressure resulting from 
the bolus being trapped or compressed between esophageal 
contractions and the incompletely relaxed EGJ. Thus 
in subtype III, there is delayed bolus arrival to the distal 
esophagus with shorter dwell time—a potential mechanism 
of dysphagia symptom generation and a pattern observed 
in patients susceptible to dysphagia post-fundoplication 
(111,113).
The CCv3.0 criteria for achalasia subtype III include 
incomplete or absent EGJ relaxation (abnormal IRP) and at 
least 20% of water swallows with esophageal contractions 
of short DL (<4.5 s). Adjunct swallow challenge test with 
RDC can confirm achalasia diagnosis by demonstrating 
EGJ dysfunction when HRM metrics for standard water 
swallows is inconclusive (Figure 5) (65,66,114). Doubt or 
debate may arise regarding diagnostic characteristics of 
achalasia subtype III cf. EGJ outflow obstruction (EGJOO). 
In EGJOO there is impaired EGJ relaxation with preserved 
primary peristalsis i.e., abnormal IRP, but intact peristalsis 
with normal DL for all standard wet swallows. A recent 
study proposes the addition of five, 5 mL liquid swallows 
during upright posture, with a 94% negative predictive 
value for revealing patients in whom IRP normalises during 
Figure 5 Achalasia or EGJ outflow obstruction 5 mL water swallow (integrated relaxation pressure IRP-4s =21 mmHg (A), however adjunct 
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upright posture (77). EGJOO is raised as a possible early 
stage or variant of achalasia, an “achalasia subtype IV” (7,80). 
Whether EGJOO is a separate entity or whether a select 
subtype of EGJOO is an early or variant of achalasia is an 
unresolved debate (7,115,116). Very few EGJOO progress 
to achalasia (115,117-119). Of note, incidental discovery 
of EGJOO (after exclusion of pseudoachalasia) is best 
managed conservatively, often with spontaneous resolution 
of symptoms (120,121).
Limitations
Limitations of HRM and CCv3.0 specific for achalasia 
includes technical or procedural issues, variation in 
pathophysiological presentation, and interpretation of 
measurements (Table 2). 
Procedural limitations
The main technical issue for HRM in achalasia is the 
motility catheter curling in the esophagus or not traversing 
the EGJ (discussed earlier). HRM analysis requires IRP 
of the EGJ relative to gastric baseline, so traversing the 
EGJ is essential for diagnosis (60,122). It is possible this 
limitation may not be recognized during or even following 
manometry, as a bent segment of the catheter coiled in the 
esophageal body, may lead to a distortion of pressure on 
the HRM recording misinterpreted as LES/EGJ pressure 
(58,123,124). Radiology guided catheter placement may 
overcome this limitation. Alternatively, the HRM catheter 
can be placed under endoscopic vision although this is 
resource intensive, carries risks associated with sedation 
including aspiration, plus the influence of conscious 
sedation agents on esophageal motility and LES pressure is 
controversial (57,125-127).
During acquisition, esophageal HRM pressure profiles 
in achalasia may show pooling of esophageal contents 
with successive water swallows; atypical esophageal or 
EGJ pressure patterns for achalasia; residual EGJ pressure 
on swallowing within the normal range; and longitudinal 
muscle pull-up of the LES impacting measurement of EGJ 
pressure. Awareness of these pressure variations during 
acquisition can prompt inclusion of adjunct swallow 
challenge tests or protocol variations, and need to be 
taken into account when applying CCv3.0 for a motility 
diagnosis.
HRM analysis limitations
Pooling of esophageal contents elevates esophageal basal 
pressures, which may create difficulty for recognizing the 
onset of esophageal contractions or pan-pressurization (111). 
Switching HRM display mode from color contour to 
pressure line plot or the use of impedance-based pressure-
flow analysis (128) is often helpful to differentiate cavity 
pressure from compartmentalized esophageal pressurization; 
for placement of HRM analysis markers; and for identifying 
the contractile deceleration point, critical for determining 
DL (13). 
During swallowing, esophageal longitudinal muscle 
contraction results in proximal ‘pull-up’ of the LES 
component of the EGJ, sometimes by several centimeters, 
which if unrecognized can be mis-interpreted as sphincter 
relaxation (EGJ pseudorelaxation) (56). Consequently 
HRM metrics will fail to meet criteria for achalasia, with 
misinterpretation as jackhammer esophagus or distal 
esophageal spasm (129). During position change to 
upright posture, incomplete transient LES relaxation may 
show a similar manometric profile with LES elevation 
(Figure 6) (7,130). Studies are needed to assess accuracy of 
achalasia subtype III diagnoses, where spastic esophageal 
contractions may mask esophageal shortening and LES 
elevation.
During HRM, we are  pr imari ly  recording the 
intraluminal pressure effects of circular muscle, not 
longitudinal muscle contractions, with an often-overlooked 
limitation of HRM: the inability to measure these separately. 
A few studies to date, using high-frequency intraluminal 
ultrasound in addition to HRM, show altered interactions 
of circular and longitudinal muscles in achalasia (110-112), 
thought to be a consequence of LES dysfunction. This 
provides insights into the variation in pathophysiology of 
achalasia subtypes, but more studies are needed to advance 
this further.
Similarly, in the absence of a hiatus hernia, HRM is 
unable to record separately LES and crural diaphragm 
pressure. When the LES and the crural diaphragm are 
aligned, EGJ pressure represents the combined synergistic 
pressure effects of both intrinsic LES and extrinsic crural 
diaphragm. Achalasia affects only LES but not crural 
diaphragm pressure, which means intraluminal pressure 
sensors measure EGJ relaxation, not LES relaxation (56). 
New 3D HRM study found an asymmetric EGJ pressure 
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Table 2 Limitations of high-resolution manometry and Chicago classification v3.0 for diagnosis of achalasia and achalasia subtypes
Limitations Solutions
Technical or procedural issues
Technical (equipment errors) Systematic check of equipment prior to procedure  
Recognition of imperfect study quality during HRM procedure or when interpreting 
the study
Catheter placement
Inability to traverse the LES Change patient posture to L- or R-lateral
Radiologic/Endoscopic catheter placement
Catheter curling in the esophagus Withdraw to 30 cm, alter posture, advance gently
Radiologic/Endoscopic catheter placement
Procedural intolerance Alternate tests supportive of diagnosis: sedated manometry, radiology (VFSS/
TBE) or FLIP 
MDT discussion
Esophageal pooling of ingested contents with study 
progression (may limit study duration)
Care in interpretation. Alternate tests supportive of diagnosis: radiology (VFSS/
TBE) or FLIP
Analysis of high-resolution manometry data
Pooling of esophageal content makes interpretation 
of bolus presence vs. contractile pressures difficult
Switch from color contour to line-plot mode
Use of esophageal pressure-impedance analysis
Difficulty identifying contractile deceleration point 
(critical for determining DL)
Manometric training and certification
Switch from color contour to line-plot mode
Use of esophageal pressure-impedance analysis
IRP-4s (median) within normal range with high index 
of suspicion (may occur: subtype I achalasia) 
Upright liquid swallows, for upright IRP-4s
Additional manometric maneuvers: MRS, RDC. Alternate tests supportive of 
diagnosis: radiology (VFSS/TBE) or FLIP. MDT discussion
EGJ ‘pseudorelaxation’ due to esophageal 
shortening from longitudinal muscle contraction
Manometric training and certification
Careful study interpretation
Incomplete transient lower esophageal sphincter 
relaxation (LES elevation without LES relaxation)
Manometric training and certification
Careful study interpretation
Use of esophageal pressure-impedance analysis
Inability to separate LES from crural diaphragm 
when aligned as EGJ
3D HRM. Radiology: VFSS/TBE
Novel metrics e.g., EGJ-contractile integral
Use of esophageal pressure-impedance analysis
Hiatus hernia Corroborate interpretation with alternate imaging sources: endoscopy, radiology
Inability to separate circular and longitudinal muscle 
activity 
Complex issue. Currently requires endoluminal-ultrasound. Not part of diagnosis 
of achalasia
Classification using Chicago Classification v3.0 
Partial expression of achalasia or variants Upright liquid swallow IRP-4s
Additional manometric maneuvers: MRS, RDC. Alternate test supportive of 
diagnosis: radiology (VFSS/ TBE) or FLIP. MDT discussion
Table 2 (Continued)
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Table 2 (Continued)
Limitations Solutions
Pseudoachalasia suspected Review clinical presentation: symptom duration; check history for prior upper GI 
surgery
Endoscopy with EGJ biopsies to exclude pathology and/or endoscopic 
ultrasonography. CT chest/abdomen. MDT discussion
Failure to exclude opioids prior to HRM study Cease opioids (as possible) for 24 hr prior to manometry. Careful study 
interpretation
Additional considerations
Appropriate high-quality interpretation Manometric training and certification
Decreased EGJ relaxation (elevated IRP) in patients 
over 80 years of age
Careful study interpretation
Care with IRP threshold; obtain supportive evidence 
Use of nitrates to induce LES relaxation Care should be taken due to small but serious risk of medication interactions or 
cardiac events
HRM, high-resolution manometry; LES, lower esophageal sphincter; VFSS, video-fluoroscopic swallowing study; TBE, timed barium 
esophagram; FLIP, functional lumen imaging probe; MDT, multi-disciplinary team; IRP-4s, integrated relaxation pressure (4 sec); DL, distal 
latency (sec); MRS, multiple rapid swallows; RDC, rapid drinking challenge; EGJ, esophagogastric junction; 3D, three dimensional. 
peak (greater curvature side) and localized the magnitude 
and orientation of crural diaphragm and LES pressure in 
achalasia, and holds great potential for future studies (131).
Chicago classification limitations
Partial expression or atypical variants of achalasia pose a 
diagnostic challenge and are currently not part of CCv3.0 
(7,56,84). HRM does not capture all achalasia, but it does 
provide clues. Partial expression of achalasia includes 
aperistalsis where residual EGJ pressure on swallowing 
is within the normal range (normal IRP) and also cases 
of aperistalsis or abnormal esophageal contractions not 
meeting the criteria for subtype I, II or III (7) (Figure 4). This 
currently unclassified group warrant further study (132). 
CCv3.0 does not classify opioid induced esophageal 
dysfunction, manifesting as elevated resting & reduced 
EGJ relaxation pressure, and LES or esophageal hyper-
contractility, including short DL (i.e., mimicking achalasia 
subtype III) (133). A large retrospective study of 66 
patients studied while taking opioids (98% short-acting), 
found 83% showed dysmotility: 45% distal esophageal 
spasm; 27% EGJOO; and 11% achalasia subtype III (134). 
Use of nitrates to induce LES relaxation may provide 
clarity (135).
With each iteration of the Chicago classification, 
the diagnosis of achalasia has been refined and yet with 
increasing complexity! The main issues identified for inter-
observer disagreement are: multiple abnormalities in a 
single study; failure to apply the hierarchical classification 
Figure 6 Incomplete transient lower esophageal sphincter 
relaxation in achalasia subtype III with proximal elevation of a non-
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scheme; lack of HRM metrics that defined pressure 
thresholds (i.e., IRP), and recognition of the frequency 
of dysmotility required for objective diagnosis (e.g., least 
20% of esophageal contractions of short DL <4.5 s) (108). 
As competency in motility testing is not easy to obtain, 
particularly for interpreting complex HRM studies (14,15), 
more attention should be given to include supplementary 
educational material with the next version of the Chicago 
classification (v4.0). 
Novel use of adjunct manometric testing in 
equivocal cases of achalasia
In certain circumstances (described above) the diagnosis 
of achalasia may be equivocal, yet a correct diagnosis is 
essential for correct treatment. Furthermore, there are 
conditions which may mimic achalasia. The classic example 
of this is ‘pseudoachalasia’ due to a distal esophageal 
malignancy (136), but recently eosinophilic esophagitis has 
also emerged as a potential mimic of achalasia (137-139). 
The use of adjunct testing during manometry, additional 
investigations, and expert consensus can facilitate correct 
diagnosis of achalasia.
To clarify observations and to overcome the limitations 
of dysmotility not revealed by small bolus swallows (140), 
at least one form of adjunct testing is recommend by the 
British Society of Gastroenterology (53,58,141). A review 
of the literature to date supports a 200 mL RDC in upright 
posture (65,74,107). However, if high aspiration risk or 
elderly, consider three MRS or five upright swallows 
(73,142). ‘Which adjunct test is most appropriate to clarify 
achalasia?’ is an important research question for a future 
version of the Chicago classification! 
Beyond HRM, additional investigations include use of a 
functional luminal imaging probe (FLIP) during endoscopy 
(143-145), dynamic video fluoroscopic swallowing studies 
(VFSS) (146,147), and a quantitative advancement, 
timed barium esophagram (TBE) (148) (Table 2). These 
technological advancements (discussed in other articles of 
this issue) provide the additional necessary evidence for 
definitive diagnosis of achalasia.
Several additional recent advancements in manometry 
may provide future direction relevant to patients with 
dysphagia and achalasia: (I) a new metric, EGJ contractile 
integral (EGJ-CI), which applies the concept of contractile 
integral (amplitude, axial length, duration) to the EGJ 
to quantify EGJ barrier pressure (unit: mmHg.cm), with 
potential to assess adequacy of achalasia treatments (149); 
(II) use of HRM with impedance, a logical extension of 
HRM, to enable detection of bolus movement e.g., a metric 
for bolus flow time across the EGJ, and also impedance 
bolus height, to assess bolus retention with promising 
utility for severity of impaired EGJ outflow and correlation 
with dysphagia in achalasia (150,151). Of note, impedance 
hardware is an additional expense and the inclusion 
of impedance rings makes for a stiffer catheter, which 
can cause difficulty traversing the EGJ; (III) automated 
impedance manometry (AIM) plot with pressure-flow 
analysis, which uniquely quantifies bolus movement 
relative to pressure events of the esophagus and EGJ (128). 
Recently applied to a paediatric achalasia cohort, the 
automated analysis generates HRIM metrics. When used in 
conjunction with software-driven diagnosis, supplemented 
by experienced observer interpretation, shows high intra-
and inter- reliability for achalasia subtyping (kappa 0.98; 0.92 
respectively) (152); (IV) Upright IRP, useful to unmask cases 
of subtle LES/EGJ obstruction (66,77). An IRP-4s above 
12 mmHg identifies patients with radiographic EGJ outflow 
obstruction (98% sensitivity; 16% specificity) (ManoScan™ 
system).
Conclusions
High resolution manometry is recommended for achalasia 
diagnosis and specific spatio-temporal metrics informs 
the structured approach of the Chicago classification for 
diagnosis of primary achalasia, categorized into three 
subtypes I, II or III. Achalasia subtypes provide greater 
understanding of the severity of achalasia at presentation 
and guide treatment decisions. Adjunct swallow challenge 
tests overcome the limitations of dysmotility not revealed by 
small bolus swallows. More research is needed to advance 
our understanding of the underlying pathophysiology. 
Meanwhile, whenever HRM reveals a non-relaxing EGJ, 
achalasia subtypes are front and center of the hierarchical 
Chicago classification process, with improved consistency of 
diagnosis.
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